RedHill Biopharma Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
IL0011223810
Pharmaceuticals
Sales 2022 | 61.8M 23.53B 84.47M | Sales 2023 | 6.53M 2.49B 8.93M | Capitalization | 28.72M 10.94B 39.26M |
---|---|---|---|---|---|
Net income 2022 | -71M -27.03B -97.05M | Net income 2023 | 23M 8.76B 31.44M | EV / Sales 2022 | 1.87 x |
Net Debt 2022 | 103M 39.1B 140M | Net cash position 2023 | 4.4M 1.67B 6.01M | EV / Sales 2023 | 3.73 x |
P/E ratio 2022 |
-0.12
x | P/E ratio 2023 |
0.4
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Dror Ben-Asher
CEO | Chief Executive Officer | 59 | 09-08-02 |
Ori Shilo
FOU | Founder | 57 | 09-08-02 |
Razi Ingber
DFI | Director of Finance/CFO | - | 23-01-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rick Scruggs
BRD | Director/Board Member | 64 | 15-12-31 |
Shmuel Cabilly
BRD | Director/Board Member | 74 | 10-08-25 |
Director/Board Member | 80 | 10-05-02 |
1st Jan change | Capi. | |
---|---|---|
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
-9.14% | 11.95B | |
+5.24% | 8.71B | |
-8.42% | 8.12B |